Montana legislation · 2025 Regular Session
Montana SB112: Revise laws related to state purchase of opioid antagonists
Status: Failed, May 23, 2025
What the bill says
A bill for an act entitled: "an act prohibiting, under certain circumstances, the use of state funds to purchase opioid overdose reversal drugs from certain entities; prohibiting certain state contracts from being renewed on or after a certain date; providing definitions; and providing an immediate effective date.".
From the engrossed text:
A BILL FOR AN ACT ENTITLED: "AN ACT PROHIBITING, UNDER CERTAIN CIRCUMSTANCES, THE USE OF STATE FUNDS TO PURCHASE OPIOID OVERDOSE REVERSAL DRUGS FROM CERTAIN ENTITIES; PROHIBITING CERTAIN STATE CONTRACTS FROM BEING RENEWED ON OR AFTER A CERTAIN DATE; PROVIDING DEFINITIONS; AND PROVIDING AN IMMEDIATE EFFECTIVE DATE." BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MONTANA: NEW SECTION. Section 1. State procurement of opioid overdose medication. (1) Except as provided in subsection (2), after June 30, 2025, state funds or available federal funding may not be used to purchase opioid antagonists from a person that was a party to or an affiliate or subsidiary of a person that was a party to a settlement with a state due to its role in the manufacture, sale, or distribution of prescription opioids. (2) The prohibition in subsection (1) does not apply to a person with a state contract to provide opioid antagonists to the state executed before July 1, 2025, until the fulfillment of the terms of the state contract. A state contract described under this subsection may not be renewed after June 30, 2025. (3) A person that agreed to provide the state with opioid antagonists as part of a settlement entered into prior to September 1, 2024, shall continue to provide the state with opioid antagonists until the …
Sponsors
- Yakawich, Mike (R, 24) · primary sponsor
Latest actions
- : (H) Died in Committee
- : (H) Tabled in Committee
- : (H) Hearing
- : (H) 1st Reading
- : (H) Referred to Committee
- : (S) Transmitted to House
- : (S) 3rd Reading
- : (S) Scheduled for 3rd Reading
- : (S) 2nd Reading
- : (S) Scheduled for 2nd Reading
Votes
- Do Pass (February 4, 2025): 49 yea, 1 nay, passed
- Do Pass (February 3, 2025): 47 yea, 1 nay, passed
Subjects: Rule Making, Alcohol, Public Contracts
Common questions
- What is SB112?
- SB112 is a bill in the Montana Legislature (2025 Regular Session): Revise laws related to state purchase of opioid antagonists.
- What does SB112 do?
- In its own words: A bill for an act entitled: "an act prohibiting, under certain circumstances, the use of state funds to purchase opioid overdose reversal drugs from certain entities; prohibiting certain state contracts from being renewed on or after a certain date; providing definitions; and providing an immediate effective date.".
- What is the status of SB112?
- Failed as of May 23, 2025. Latest action: (H) Died in Committee (May 23, 2025).
- Who sponsored SB112?
- Yakawich, Mike (R, 24).
- Where is the official record for SB112?
- On the Montana Legislature website: https://bills.legmt.gov/#/laws/bill/2/LC2083
Source: official Montana record. Tracked by Delilah, AI for legislation across all 50 states and Congress.